EDAP TMS S.A. (NASDAQ:EDAP) is reporting second quarter earnings results on Wednesday 26th August 2020, after market close.
The consensus estimates from Thomson Reuters are loss of $ 0.08 per share.
For the full year, analysts predict revenues of $ 33.15 million, while looking forward to loss of $ 0.22 per share.
Previous Quarter Performance
EDAP TMS S.A. came out with loss for the first quarter of $ 0.05 per share, from the revenue of $ 8.29 million. The consensus estimates are loss of $ 0.03 per share from $ 9.16 million in revenue. The bottom line results missed street analysts by $ 0.02 or 66.67 percent, at the same time, top line results fell short of analysts by $ 0.87 million or 9.5 percent.
Stock Performance
Shares of EDAP TMS S.A. traded high $ 0.15 or 4.62 percent on Tuesday, reaching $ 3.40 with volume of 90.60 thousand shares. The stock opened positive for the day at $ 3.27, after closing the previous day trading at $ 3.25.
According to the previous trading day, closing price of $ 3.25, representing a 122.60 % increase from the 52 week low of $ 1.46 and a 39.7 % decrease over the 52 week high of $ 5.39.
The company has a market capital of $ 99.08 million and is part of the Healthcare sector and Medical Devices industry.
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. It operates in two divisions, High Intensity Focused Ultrasound (HIFU) and Urological Devices and Services (UDS). The HIFU division develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications.
